Position 2: Transarterial Radioembolization Should Be the Primary Locoregional Therapy for Unresectable Hepatocellular Carcinoma
Syed Irfan‐Ur Rahman, Laura Nunez‐Herrero, Jamie Lee Berkes – 26 March 2020
Development of Hepatocellular Carcinoma in Patients With Suppressed Viral Replication: Changes in Risk Over Time
Prowpanga Udompap, W. Ray Kim – 26 March 2020
Position 1: Transarterial Chemoembolization Should Be the Primary Locoregional Therapy for Unresectable Hepatocelluar Carcinoma
Wasseem Skef, Mitali Agarwal, Adam E. Mikolajczyk – 26 March 2020
Parenteral Nutrition–Associated Liver Disease
Kristen Nowak – 26 March 2020
Reply
Damiano Patrono, Eloisa Franchi, Francesco Lupo, Renato Romagnoli – 26 March 2020
Spotlight on Impactful Research: Utilization of Aspirin and Statin in Management of Coronary Artery Disease in Patients With Cirrhosis Undergoing Liver Transplant Evaluation
Leana Frankul, Catherine T. Frenette – 26 March 2020
Checkpoint Inhibitors for the Treatment of Advanced Hepatocellular Carcinoma
Laura A. Huppert, John D. Gordan, Robin Kate Kelley – 26 March 2020
Checkpoint Inhibitors for the Treatment of Advanced Hepatocellular Carcinoma
Laura A. Huppert, John D. Gordan, Robin Kate Kelley – 26 March 2020
Living Donor Liver Transplantation When Deceased Donor Is Not Possible or Timely: Case Examples and Ethical Perspectives
Alexandra Shingina, Martin Montenovo – 25 March 2020
Vascular Remodeling of Visceral Arteries Following Interruption of the Splenic Artery During Liver Transplantation
Salvatore Gruttadauria, Duilio Pagano, Settimo Caruso, Davide Cintorino – 25 March 2020